Formosa Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 18

Employees

  • Stock Symbol
  • 6838

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.61
  • (As of Thursday Closing)

Formosa Pharmaceuticals General Information

Description

Formosa Pharmaceuticals Inc is engaged in new drug development and transfers. Its Product pipeline includes TSY-110, TSY-120, TSY-310, APP13007 and APP13002.

Contact Information

Website
www.formosapharma.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 8F-6, No. 57, Fuxing North Road
  • Songshan District
  • Taipei, 105
  • Taiwan
+886 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TAI
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • 8F-6, No. 57, Fuxing North Road
  • Songshan District
  • Taipei, 105
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Formosa Pharmaceuticals Stock Performance

As of 12-Nov-2026, Formosa Pharmaceuticals’s stock price is $0.61. Its current market cap is $92M with 151M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.61 $0.62 $0.60 - $1.04 $92M 151M 138K -$0.04

Formosa Pharmaceuticals Financials Summary

As of 30-Jun-2026, Formosa Pharmaceuticals has a trailing 12-month revenue of $1.69M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 72,705 79,915 122,168 178,282
Revenue 1,693 304 4,467 1,001
EBITDA (5,090) (1,899) (4,921) (8,593)
Net Income (6,118) (2,679) (6,264) (10,336)
Total Assets 60,381 66,229 64,234 56,196
Total Debt 775 863 785 969
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Formosa Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Formosa Pharmaceuticals‘s full profile, request access.

Request a free trial

Formosa Pharmaceuticals Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Formosa Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023446460-A1 Method of treating operative complications of cataract surgery Pending 01-May-2023
EP-4704853-A1 Method of treating operative complications of cataract surgery Pending 01-May-2023
US-20240366631-A1 Method of treating operative complications of cataract surgery Pending 01-May-2023
WO-2024228699-A1 Method of treating operative complications of cataract surgery Inactive 01-May-2023
JP-2026524248-A Treatment methods for surgical complications of cataract surgery Pending 01-May-2023 A61K9/0048
To view Formosa Pharmaceuticals’s complete patent history, request access »

Formosa Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Formosa Pharmaceuticals Acquisitions (1)

Formosa Pharmaceuticals’s most recent deal was a Merger/Acquisition with Activus Pharma for . The deal was made on 10-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Activus Pharma 10-Aug-2017 Merger/Acquisition Drug Discovery
To view Formosa Pharmaceuticals’s complete acquisitions history, request access »

Formosa Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Formosa Pharmaceuticals’s complete esg history, request access »

Formosa Pharmaceuticals FAQs

  • When was Formosa Pharmaceuticals founded?

    Formosa Pharmaceuticals was founded in 2010.

  • Where is Formosa Pharmaceuticals headquartered?

    Formosa Pharmaceuticals is headquartered in Taipei, Taiwan.

  • What is the size of Formosa Pharmaceuticals?

    Formosa Pharmaceuticals has 18 total employees.

  • What industry is Formosa Pharmaceuticals in?

    Formosa Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Formosa Pharmaceuticals a private or public company?

    Formosa Pharmaceuticals is a Public company.

  • What is Formosa Pharmaceuticals’s stock symbol?

    The ticker symbol for Formosa Pharmaceuticals is 6838.

  • What is the current stock price of Formosa Pharmaceuticals?

    As of 12-Nov-2026 the stock price of Formosa Pharmaceuticals is $0.61.

  • What is the current market cap of Formosa Pharmaceuticals?

    The current market capitalization of Formosa Pharmaceuticals is $92M.

  • What is Formosa Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for Formosa Pharmaceuticals is $1.69M.

  • What is Formosa Pharmaceuticals’s annual earnings per share (EPS)?

    Formosa Pharmaceuticals’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process